SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarti Drugs informs about conference call

28 Jan 2022 Evaluate
Aarti Drugs has informed that Quarterly Conference Call for the Investors and Analysts has been scheduled on Wednesday, February 2, 2022 at 11:00 AM IST to discuss the Company's financial performance for the Quarter and nine months ended December 31, 2021. 

The above information is a part of company’s filings submitted to BSE.

Aarti Drugs Share Price

381.95 -6.50 (-1.67%)
11-May-2026 09:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1839.85
Dr. Reddys Lab 1293.00
Cipla 1340.75
Zydus Lifesciences 940.00
Lupin 2344.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×